Sign Up to like & get recommendations! 1
Published in 2021 at "Dermatology and Therapy"
DOI: 10.1007/s13555-021-00499-8
Abstract: The study aimed to evaluate the real-world effectiveness of adalimumab as well as investigate the persistence of treatment and identify factors, which may affect it. More than 1150 patients (4363.1 patient-years) with psoriasis who had… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2022.2113800
Abstract: PURPOSE To report a case of multiple sclerosis (MS) development in a patient with Juvenile Idiopathic Arthritis (JIA) and bilateral intermediate uveitis (IU) treated with Adalimumab. CASE REPORT A 21-year-old Colombian woman diagnosed with JIA… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13327
Abstract: Dear Editor, Acrodermatitis continua of Hallopeau (ACH) is an uncommon chronic, inflammatory, and relapsing disease manifesting as sterile pustules of the fingers and toes with possible involvement of nail bed. ACH is often refractory to… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13422
Abstract: Dear Editor, Since Lubeck et al published the first article on tattoo complications in 1952, there have already been numerous articles on tattoo-related health problems. In the last 15 years, the tattoo trend in society… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pediatric Dermatology"
DOI: 10.1111/pde.14321
Abstract: Isotretinoin is widely used in severe acne. Isotretinoin has many side effects. Sacroiliitis is one of these side effects and has been rarely reported in the children. Herein, we present two children with isotretinoin‐induced sacroiliitis… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "BMJ Case Reports"
DOI: 10.1136/bcr-2023-254742
Abstract: This article presents two consecutive cases of laryngeal tuberculosis in patients treated with a specific anti-tumour necrosis factor-alpha (adalimumab), with a focus on their diagnostic process and therapeutic management. Both patients presented with aspecific chronic… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2018-09-877399
Abstract: ![Figure][1] A 53-year-old morbidly obese woman diagnosed with Crohn disease 3 years earlier was being treated with adalimumab (40 mg per 15 days) and methotrexate (15 mg per week). She presented with severe fatigue and… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Orvosi hetilap"
DOI: 10.1556/650.2022.32578
Abstract: INTRODUCTION Biological therapy can be used in uveitis in children since 2016. With ophthalmological indication only adalimumab therapy can be started. Adalimumab is a monoclonal antibody that inhibits tumor necrosis factor alpha. OBJECTIVE To summarize… read more here.